Tagged with S

Eli Lilly Polska You joined Eli Lilly Poland in November 2008 as a Marketing Director and you have been leading the affiliate since January 2010. Moreover you are co-chairing the LAWG – Local Area Working Group – a group of R&D based pharmaceutical companies in Poland, since July 2010, so 2010 was a…

Espacio Riesco You are by far the largest Convention Centre in Chile. When was it decided to construct such an impressive event area and what was the vision behind the creation of Espacio Riesco? The idea of Espacio Riesco came up in 1998 and the first phase of the construction ended in…

Servier China In 2012 Servier China became the 3rd largest affiliate within the Servier group. How has the company progressed since then? Servier-China is a linchpin for Servier. Servier-China has become the biggest subsidiary in terms of personnel, with over 1200 people, and today we are number one in the Company in…

GlaxoSmithKline pharmaceuticals S.A. In the pharma world, managers change frequently from one company to another, and this phenomenon has been accelerated with the consolidation of the market, however you chose to dedicate your entire professional career to GlaxoSmithKline (GSK), that you joined in 1992. What has kept you within the group, what has…

polski holding farmaceutyczny (PHF) Polski Holding Farmaceutyczny (PHF) was put together in 2004 as a capital group consisting of three leading Polish pharma producers and the mission given by the State Treasury Minister was to privatise the three entities. You joined in March 2008, at a time when, if I may say, major steps…

Polpharma SA For years Polpharma has been the market leader in Poland. In many countries the arrival of multinational companies (MNCs) led to the loss of leadership by the historical players to the benefit of MNCs. How has the arrival of GSK, Teva or Sandoz, altered the playing field for the company…

Servier Poland Unlike many pharmaceutical companies, Servier fully operates in all pharma business activities in Poland: research, drug manufacturing and distribution, and health education. Considering your extensive international and regional experience in Romania, Russia, and Bulgaria, but also Vietnam, what is unique here? What is there in Poland that is attracting the…

Torrex Chiesi Poland Would you begin by explaining to the readers of Pharmaceutical Executive the importance of the operation in Poland for the company? Indeed Poland because of largest in CEE pharmaceutical market size was always very attractive for all pharmaceutical companies, although it is a very complex market. For those coming to…

Johnson&Johnson Romania In order to provide our readers with a general idea of the current state of the Romanian pharmaceutical and healthcare sectors, can you first of all elaborate on the key particularities of this market? Romania has been a member of the EU since 2009, is a potential member of the…

Quintiles Poland Firstly, what attracted you to join the CRO industry with Quintiles over 10 years ago? I had been working for 5 years as a doctor in the internal medicine and intensive care departments of the Warsaw medical school. The team there was already conducting some medical research in the clinic.…

Servier Brasil When we met Servier Brazil five years ago the company had major ambitions: ‘grow more than 10% for the five following years’. How have these expectations turned out to be? Actually, these projections turned out to be quite conservative. In the last two years Servier has doubled its Brazilian revenues…

Novartis Argentina When we met with Javier Lombar at IMS Argentina, he was explaining how a lot of multinational companies are using Argentina as a regional base of operations. Novartis is a prime example of this. Could you explain how Novartis operates in a Latin American context, and what role the Argentinean…